LORIA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 15.592
EU - Europa 6.689
AS - Asia 1.817
SA - Sud America 21
AF - Africa 13
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.152
Nazione #
US - Stati Uniti d'America 15.569
GB - Regno Unito 2.591
IT - Italia 998
SE - Svezia 936
CN - Cina 778
DE - Germania 760
UA - Ucraina 538
TR - Turchia 453
HK - Hong Kong 387
FI - Finlandia 287
BG - Bulgaria 204
FR - Francia 175
RU - Federazione Russa 48
IN - India 47
BE - Belgio 29
NL - Olanda 28
SG - Singapore 28
MY - Malesia 21
CA - Canada 18
ES - Italia 16
JP - Giappone 15
LT - Lituania 15
IR - Iran 14
ID - Indonesia 13
IE - Irlanda 13
BD - Bangladesh 11
KR - Corea 10
RO - Romania 10
TW - Taiwan 10
AU - Australia 8
CL - Cile 8
CH - Svizzera 7
EU - Europa 7
SI - Slovenia 6
AT - Austria 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
IQ - Iraq 5
MX - Messico 5
AR - Argentina 4
BR - Brasile 4
NZ - Nuova Zelanda 4
PH - Filippine 4
UG - Uganda 4
VN - Vietnam 4
CY - Cipro 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
EC - Ecuador 2
EG - Egitto 2
HR - Croazia 2
KW - Kuwait 2
PK - Pakistan 2
PL - Polonia 2
RS - Serbia 2
TH - Thailandia 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
JO - Giordania 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
VE - Venezuela 1
Totale 24.152
Città #
Fairfield 2.189
Southend 2.017
Woodbridge 1.601
Houston 1.276
Jacksonville 1.218
Chandler 1.197
Ashburn 1.135
Seattle 832
Dearborn 796
Ann Arbor 776
Wilmington 761
Cambridge 720
Nyköping 546
Hong Kong 383
Modena 303
Beijing 300
Izmir 283
San Diego 235
Princeton 220
Sofia 204
Eugene 201
Des Moines 166
New York 141
Grafing 101
Helsinki 90
Falls Church 86
London 82
Shanghai 67
Bremen 58
Milan 46
Boardman 41
Redwood City 39
Rome 39
Norwalk 35
Kunming 34
San Mateo 33
Fremont 31
Hefei 31
Brussels 26
Kilburn 23
Bologna 19
Guangzhou 19
Nanjing 19
Verona 19
Hounslow 18
Bari 17
Jinan 17
Dongguan 16
Singapore 15
Chiswick 14
Nanchang 14
Frankfurt am Main 13
Jakarta 13
Dublin 11
Parma 11
Indiana 10
Phoenix 10
Auburn Hills 9
Augusta 9
Florence 9
Shenyang 9
Taipei 9
Formia 8
Genova 8
Islington 8
Leawood 8
Madrid 8
Mountain View 8
Saint Petersburg 8
San Francisco 8
Toronto 8
Amsterdam 7
Baotou 7
Chicago 7
Fuzhou 7
Turin 7
Washington 7
Chengdu 6
Chongqing 6
Dhaka 6
Istanbul 6
Los Angeles 6
Monmouth Junction 6
Monza 6
Napoli 6
Prescot 6
Rio Saliceto 6
Santeramo in Colle 6
Sydney 6
Baghdad 5
Bangalore 5
Hebei 5
Livorno 5
Nishinotoindori 5
Wandsworth 5
Avigliano 4
Busto Arsizio 4
Castelnuovo Rangone 4
Clearwater 4
Hanover 4
Totale 18.898
Nome #
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 296
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 260
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 219
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 214
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 213
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 203
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 201
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 201
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 195
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 189
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 187
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 187
Gender, fatty liver and GGT 186
Nonalcoholic fatty liver disease and aging: epidemiology to management 186
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 180
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 178
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 176
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 176
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 176
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 175
Risk factors for hospital readmission of elderly patients 172
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 170
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 170
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 169
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 169
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 169
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 168
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 167
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 166
Review article: diabetes, genetics and ethnicity 164
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 161
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 157
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 157
Endocrine and liver interaction: the role of endocrine pathways in NASH 157
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 155
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 154
The hepatitis C virus-associated dysmetabolic syndrome. 154
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 153
Advances in the comprehension of the pathophysiology of bile secretion 151
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 151
From NAFLD in clinical practice to answers from guidelines. 151
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 151
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 151
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 151
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 149
Effects of acute changes of bile acid pool composition on biliary lipid secretion 147
Statins and HCV: a complex issue 147
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors. 147
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 145
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 144
NAFLD and cardiovascular risk: direct evidence for the tale of two ages. 143
Chicken or egg turned into head or belly 142
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 142
Review article: hepatic steatosis and insulin resistance 142
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 141
Progetto MICOL - Multicentrica Italiana Colelitiasi 141
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 140
Growth hormone plasma levels in nonalcoholic fatty liver disease 138
Of liver, whisky and plants: A requiem for colchicine in alcoholic cirrhosis? 138
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 138
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 137
Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree? 137
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 137
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 136
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease -Atherosclerosis As a Major Player in the Natural Course of NAFLD. 136
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 135
Apolipoprotein synthesis in nonalcoholic steatohepatitis 135
Nonalcoholic fatty liver disease induced by leuprorelin acetate 135
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 135
Liver and diabetes. A vicious circle 134
Fisiologia della secrezione biliare. 132
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 132
Metabolic alterations and chronic hepatitis C: treatment strategies. 132
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 131
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 131
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 131
Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid 130
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 130
Influence of age and sex on serum concentrations of total dimeric activin A 129
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 129
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? 129
Dysmetabolic changes associated with HCV: a distinct syndrome? 128
Anatomia e fisiologia delle vie biliari 127
Hepatitis C and diabetes: the inevitable coincidence? 127
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 127
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 127
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 127
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 127
Effect of ursocholic acid on bile lipid secretion and composition 126
Presentation of the RIFLE Project : Risk factors and life expectancy. 126
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 126
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 125
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 125
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 124
Diet and gallstones in Italy: the cross-sectional MICOL results. 124
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 124
Role of body mass index in the prediction of all cause mortality in over 62,000 men and women. The Italian RIFLE Pooling Project. Risk Factor and Life Expectancy. 124
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 124
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 124
Bile acid structure and regulation of biliary protein secretion and composition in man 123
Totale 15.298
Categoria #
all - tutte 97.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019881 0 0 0 0 0 0 0 0 0 0 0 881
2019/20205.450 399 404 194 358 569 865 941 502 474 172 332 240
2020/20213.733 363 139 324 320 391 294 369 545 133 452 257 146
2021/20223.583 51 502 394 313 87 156 261 204 392 213 607 403
2022/20233.279 363 354 205 326 401 583 72 310 385 29 142 109
2023/20241.887 84 119 114 136 457 221 216 286 56 42 75 81
Totale 24.301